January 2022

CMV Vaccine Workshop Overview

Author: Hannah Hopkins Goldberg National CMV Foundation was proud to be a co-organizer of the recent CMV Vaccine Development Workshop, which took place last month. Learn more about this amazing meeting from National CMV Foundation intern Hannah Hopkins Goldberg. 

COVID-19 Vaccine in Children With Disabilities and Complex Healthcare Needs

Author: Dr. Kathleen Muldoon & Dr. Megan Pesch The kid-sized Pfizer-BioNTech COVID-19 vaccine was recently authorized for children 5 to 11 years of age. 28 million children are now eligible for vaccination, including approximately 1 in 6 children with a developmental disability. [1]  Recent statistics show why pediatricians and infectious disease experts at the National CMV Foundation support the vaccine for younger children, including for children with disabilities.